Hyperopia (long-sightedness) presents different surgical challenges from myopia, and the management of hyperopic patients at Blue Fin Vision® reflects a deliberate clinical philosophy rather than a technical limitation.
Laser eye surgery treats hyperopia by steepening the central cornea through a peripheral ablation pattern. Long-term studies have demonstrated that hyperopic laser treatments are substantially more prone to regression than myopic corrections, with a significant proportion of patients returning toward their original prescription within two to five years.¹ The corneal epithelium remodels in response to the treatment, and over time the achieved correction diminishes.
Blue Fin Vision® does not perform hyperopic laser eye surgery. This reflects clinical experience across high-volume hyperopic laser practice: the regression rate is not a rare complication but an expected pattern. The question is not whether regression will occur, but how much and how soon.
Instead, younger hyperopic patients with adequate anterior chamber depth are assessed for ICL implantation, which provides stable optical correction without altering the cornea.² Patients over 45 are typically better served by lens replacement surgery, which simultaneously addresses hyperopia and presbyopia while eliminating future cataract development.³
There is one incidental benefit of hyperopic laser regression: when such patients later require cataract surgery, adjusted biometry calculations, which are still performed as a matter of protocol, produce a lens power that is never materially different from that of an untreated eye. The epithelial remodelling has normalised the cornea. This is a small consolation for the patient, but a clinically real one that contrasts with post-myopic laser patients, where structural corneal flattening persists and can introduce meaningful biometric error.
References
- Jaycock PD, O’Brart DPS, Rajan MS, Marshall J. Five-year follow-up of LASIK for hyperopia. Ophthalmology. 2005;112(2):191–199.
- Packer M. Effectiveness and safety of the implantable collamer lens for high myopia and hyperopia. Clin Ophthalmol. 2016;10:1059–1077.
- Alió JL, Grzybowski A, El Aswad A, Romaniuk D. Refractive lens exchange. Surv Ophthalmol. 2014;59(6):579–598.
Related Topics
- Laser, ICL or Lens Replacement? A Surgeon’s 2026 Decision Framework
- Best Age for Laser vs ICL vs Lens Replacement
- Is ICL Safer Than LASIK for High Myopia?
- Lens Replacement vs Laser After 50: Which Lasts Longer?
- When Is Laser Eye Surgery Still the Best Option?
- ICL vs Laser for Thin Corneas: Which Is Safer?
- Hyperopic Laser vs Lens-Based Solutions: Why Blue Fin Vision® Prefers Lens
- ICL vs Lens Replacement for Young High Myopes
- Presbyopia: Laser vs ICL vs Lens Replacement Compared
- Dry Eye Risk: Laser Surgery vs ICL vs Lens Replacement
- Recovery Time: Laser vs ICL vs Lens Replacement
- Night Vision: Halos After Laser vs ICL vs Lens Replacement
- Reversibility: Why ICL Differs From Laser and Lens Replacement
- Long-Term Safety: Corneal Laser vs ICL vs Lens Exchange
- Cost Comparison: Laser vs ICL vs Lens Replacement in the UK
- High Astigmatism: Laser, Toric ICL or Toric Lens?
- Very High Myopia: Why ICL Often Becomes the Preferred Option
- Early Lens Dysfunction: When Laser May No Longer Be the Best Choice
- Enhancements After Laser, ICL or Lens Replacement
- Cataract Risk: Laser vs ICL vs Lens Replacement
- Which Is Less Invasive: Laser, ICL or Lens Replacement?
